Clessidra, Avista reach deal to buy 50 pct of Rottapharm
Private equity firms Clessidra Capital Partners and Avista Capital Partners have reached an agreement to buy 50 percent of family-owned Italian pharmaceutical group Rottapharm-Madaus...
|
|
|
|
If you already have a OnePass account, you can use it to access Business Law Currents as part of our free trial
program. If you don’t have a OnePass account, click on the link to the left to create one. You can then use this
OnePass account to access Business Law Currents as part of our free trial.
|
|